5 (458) · $ 5.50 · In stock
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
Vaccines ++ – COVID Reference
Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine
Applications of genetic engineering in COVID-19
Structural and energetic analyses of SARS-CoV-2 N-terminal domain characterise sugar binding pockets and suggest putative impacts of variants on COVID-19 transmission - Computational and Structural Biotechnology Journal
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies, The Egyptian Journal of Internal Medicine
Vaccines ++ – COVID Reference
Junzhi Wang's research works National Institutes for Food and Drug Control, China, Beijing (NIFDC) and other places
COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies
Mechanisms of SARS-CoV-2 entry into cells